Contact lens associated corneal infections. Where do we go from here?

Clinical and Experimental Optometry

Volumn 85, Issue 3, 2002, Pages 141-148

  Giese, Michael J ^a,b   Weissman, Barry A ^a  

^a Ocular Inflammatory Disease Center   (United States)

^b JULES STEIN EYE INSTITUTE   (United States)

Author keywords

Contact lens; Infectious keratitis

Indexed keywords

BACTERIAL EYE INFECTION; CONTACT LENS; EXTENDED WEAR CONTACT LENS; FORECASTING; HUMAN; KERATITIS; MICROBIOLOGY; REVIEW; RISK FACTOR;

CONTACT LENSES; CONTACT LENSES, EXTENDED-WEAR; EYE INFECTIONS, BACTERIAL; FORECASTING; HUMANS; KERATITIS; RISK FACTORS;

EID: 0036559250     PISSN: 08164622     EISSN: 14440938     Source Type: Journal    
DOI: 10.1111/j.1444-0938.2002.tb03026.x     Document Type: Review

References (82)

1. Dixon JM, Young CA Jr, Baldone JA, Halberg G P, Sampson W, Stone W Jr. Complications associated with the wearing of contact lenses. JAMA 1966;195:901-903.
2. Freedman H, Sugar J. Pseudomonas keratitis following cosmetic soft contact lens wear. Contact Lens J 1976;10:21-25.
3. Cooper RL, Constable IJ. Infective keratitis in soft contact lens wearers. Br J Ophthalmol 1977;61:250-254.
4. Krachmer JH, Purcell JJ Jr. Bacterial corneal ulcers in cosmetic soft contact lens wearers. Arch Ophthalmol 1978;96:57-61.
5. Wilson LA, Schlitzer RL, Ahearn DG. Pseudomonas corneal ulcers associated with soft contact lens wear. Am J Ophthalmol 1981;92:546-554.
6. Mondino BJ, Weissman BA, Farb MD, Pettit TH. Corneal ulcers associated with dailywear and extended-wear contact lenses. Am J Ophthalmol 1986;102:58-65.
7. Asbell P, Stenson S. Ulcerative keratitis: a survey of 30 years' laboratory experience. Arch Ophthalmol 1982;100:77-80.
8. Wilhelmus KR. Review of clinical experience with microbial keratitis associated with contact lenses. CLAO J 1987;13:211-214.
9. Wilhelmus KR. Bacterial keratitis. In: Pepose JS, Holland GN, Wilhemus KR, eds. Ocular Infection and Immunity. St Louis: Mosby-Year Book Inc. 1996; 970-1031.
10. Donzis PB, Mondino BJ, Weissman BA, Bruckner DA. Microbial analysis of contact lens care systems contaminated with Acanthamoeba. Am J Ophthalmol 1989;108:53-56.
11. Weissman BA, Giese MJ, Mondino BJ: Ulcerative bacterial keratitis. In: Silbert JA, ed. Anterior Segment Complications of Contact Lens Wear, 2nd ed. Boston: Butterworth-Heinemann, 2000: 225-250.
12. Ruben M. Acute eye disease secondary to contact-lens wear. Lancet 1976;1:138-140.
13. Donzis PB, Mondino BJ, Weissman BA, Bruckner DA. Microbial contamination of contact lens care systems. Am J Ophthalmol 1987;104:325-333.
14. Garwood PC. Complications with daily-wear disposable contact lenses. Contact Lens J 1991;19:137-141.
15. Schein OD, Glynn RJ, Poggio EC, Seddon JM, Kenyon KR. The relative risk of ulcerative keratitis among users of daily-wear and extended-wear soft contact lenses: a case control study. Microbial Keratitis Study Group. N Engl J Med 1989;321:773-778.
16. Sharma S. Levels of evidence. Evidence Based Eye Care 2000;1:67-68.
17. Early treatment diabetic retinopathy study design and baseline patient characteristics. ETDRS report number 7. Ophthalmology 1991;98(Suppl 5):741-756.
18. Design and methods of a clinical trial for a rare condition: the Collaborative Ocular Melanoma Study. COMS Report number 3. Control Clin Trials 1993;14:362-391.
19. Poggio EC, Glynn RJ, Schein OD, Seddon JR, Schannon MJ, Scardino VA, Kenyon KR. The incidence of ulcerative keratitis among users of daily-wear and extended-wear soft contact lenses. N Engl J Med 1989;321:779-783.
20. Chalupa E, Swarbrick HA, Holden BA, Sjö;strand J. Severe corneal infections associated with contact lens wear. Ophthalmology 1987;94:17-22.
21. MacRae S, Herman C, Stulting RD, Lippman R, Whipple D, Cohen E, Egan D, Wilkinson CP, Scott C, Smith R, Phillips D. Corneal ulcer and adverse reaction rates in premarket contact lens studies. Am J Ophthalmol 1991;111:457-465.
22. Barr J. The 1997 report on contact lenses. Contact Lens Spectrum 1998;1:23-33.
23. Cheng KH, Leung SL, Hoekman HW, Beekhuis WH, Mulder PC, Geerards AT, Kijlstra A. Incidence of contact-lensassociated microbial keratitis and its related morbidity. Lancet 1999;354:181-185.
24. Koidou-Tsiligianni A, Alfonso E, Forster RK. Ulcerative keratitis associated with contact lens wear. Am J Ophthalmol 1989;108:64-67.
25. Donnenfeld ED, Cohen EJ, Arentsen JJ, Genvert GI, Laibson PR. Changing trends in contact lens associated corneal ulcers: an overview of 116 cases. CLAO J 1986;12:145-149.
26. Schein OD, Ormerod LD, Barraquer E, Alfonso E, Egan KM, Paton BG, Kenyon KR. Microbiology of contact lens related keratitis. Cornea 1989;8:281-285. (Pubitemid 19242716)
27. Rattanatam T, Heng WJ, Rapuano CJ, Laibson PR, Cohen EJ. Trends in contact lens-related corneal ulcers. Cornea 2001;20:290-294.
28. Stein RM, Clinch TE, Cohen EJ, Genvert GI, Arentsen JJ, Laibson PR. Infected vs sterile corneal infiltrates in contact lens wearers. Am J Ophthalmol 1988;105:632-636.
29. Mondino BJ, Groden LR. Conjunctival hyperemia and corneal infiltrates with chemically disinfected soft contact lenses. Arch Ophthalmol 1980;98:1767-1770.
30. Gordon A, Kracher GP. Corneal infiltrates and extended-wear contact lenses. J Am Optom Assoc 1985;56:198-201.
31. Baum J, Dabezies OH Jr. Pathogenesis and treatment of 'sterile' midperipheral corneal infiltrates associated with soft contact lens use. Cornea 2000;19:777-781.
32. Vaughn DG Jr. Corneal ulcers. Surv Ophthalmol 1958;3:203-215.
33. Hyndiuk RA, Glasser DB. Herpes Simplex Keratitis. In: Tabbara KF, Hyndiuk RA, eds. Infections of the Eye, 2nd ed. Boston: Little Brown and Co, 1996: 361.
34. O'Brien TP, Hazlett LD. Pathogenesis of ocular infection. In: Pepose JS, Holland GN, Wilhemus KR, eds. Ocular Infection and Immunity. St. Louis: Mosby-Year Book Inc. 1996; 200-214.
35. Hazlett LD, Masinick S. Lacrimal Gland, Tear Film, and Dry Eye Syndromes, 2nd ed. New York, Plenum Press, 1998: 567-574.
36. Chen LD, Hazlett LD. Perlecan in the basement membrane of corneal epithelium serves as a site of P. aeruginosa binding. Curr Eye Res 2000;20:260-267.
37. Kilian M, Reinholdt J, Lomholt H, Poulsen K, Frandsen EV. Biological significance of IgA1 protease in bacterial colonization and pathogenesis: critical evaluation of experimental evidence. APMIS 1996;104:321-338.
38. O'Callaghan RJ. Role of exoproteins in bacterial keratitis: the Fourth Annual Thygeson Lecture, presented at the Ocular Microbiology and Immunology Group meeting, November 7, 1998. Cornea 1999;18:532-537.
39. Hazlett LD, Iglewski BH, Berk RS. Experimental Pseudomonas exotoxin A mediated ocular damage in mouse pups: microscopic observations, Ophthalmic Res 1982;14:401-408.
40. Ohman DE, Burns RP, Iglewski BH. Corneal infections in mice with toxin A and elastase mutants of Pseudomonas aeruginosa. J Infect Dis 1980;142:547-555.
41. Howe TR, Iglewski BH. Isolation and characterization of alkaline protease-deficient mutants of Pseudomonas aeruginosa in vitro and in a mouse eye model. Infect Immun 1984: 43: 1058-1063.
42. Engel LS, Hill JM, Moreau JM, Green LC, Hobden JA, O'Callaghan RJ. Pseudomonas aeruginosa protease IV produces corneal damage and contributes to bacterial virulence. Invest Ophthalmol Vis Sci 1998;39:662-665.
43. O'Callaghan RJ, Callegan MC, Moreau JM, Green LC, Foster TJ, Hartford OM, Engel LS, Hill JM. Specific roles of alpha-toxin and beta-toxin during Staphylococcus aureus cornea infection. Infect Immun 1997;65:1571-1578.
44. Twining SS, Lohr KM, Moulder JE. The immune system in experimental Pseudomonas keratitis. Model and early effects. Invest Ophthalmol Vis Sci 1986;27:507-515.
45. Van Horn DL, Davis SD, Hyndiuk RA, Pederson HJ. Experimental Pseudomonas keratitis in the rabbit: bacteriologic, clinical, and microscopic observations. Invest Ophthalmol Vis Sci 1981;20:213-221.
46. Hume EB, Dajcs JJ, Moreau JM, Sloop GD, Willcox MD, O'Callaghan RJ. Staphylococcus corneal virulence in a new topical model of infection. Invest Ophthalmol Vis Sci 2001: 42: 2904-2908.
47. Van Horn DL, Davis SD, Hyndiuk RA, Alpren TV. Pathogenesis of experimental Pseudomonas keratitis in the guinea pig: bacteriologic, clinical, and microscopic observations. Invest Ophthalmol Vis Sci 1978;17:1076-1086.
48. Cowell BA, Wu C, Fleiszig SMJ. Use of animal model in studies of bacterial corneal infection. ILAR J 1999;40:43-50.
49. Cole N, Willcox MD, Fleiszig SM, Stapleton F, Bao B, Tout S, Husband A. Different strains of Pseudomonas aeruginosa isolated from ocular infections or inflammation display distinct corneal pathologies in an animal model. Curr Eye Res 1998;17:730-735.
50. Fleiszig SMJ, Zaidi TS, Preston MJ, Grout M, Evans DJ, Pier GB. Relationship between cytoxicity and corneal epithelial cell invasion by clinical isolates of Pseudomonas aeruginosa. Infect Immun 1996;64:2288-2294.
51. 2 in rabbit tears: A host defence against Staphylococcus aureus. Invest Ophthalmol Vis Sci 2001;42:2347-2354.
52. Sack RA, Beaton AR, Sathe S. Diurnal variations in angiostatin in human tear fluid: a possible role in prevention of corneal neovascularization. Curr Eye Res 1999;18:186-193.
53. Waldrep JC, Mondino BJ. Humoral immunity and the eye. In: Pepose JS, Holland GN, Wilhemus KR, eds. Ocular Infection and Immunity. St. Louis: Mosby-Year Book Inc. 1996; 33-49.
54. Szczotka LB, Cocuzzi E, Medof ME. Decayaccelerating factor in tears of contact lens wearers and patients with contact lens associated complications. Optom Vis Sci 2000;77:586-591.
55. Sack RA, Sathe S, Hackwood LA, Willcox MD, Holden BA, Morris CA. The effect of eye closure on protein and complement composition on Group IV hydrogel lenses: relationship to tear flow dynamics. Curr Eye Res 1996;15:1092-1100.
56. Cleveland RP, Hazlett LD, Leon MA, Berk RS. Role of complement in murine corneal infection caused by Pseudomonas aeruginosa. Invest Ophthalmol Vis Sci 1983;24:237-242.
57. Mondino BJ, Zaidman GW. Hemolytic complement in tears. Ophthalmic Res 1983;15:208-211.
58. Knop N, Knop E. Conjunctiva associated lymphoid tissue in the human eye. Invest Ophthalmol Vis Sci 2000;41:1270-1279.
59. Allensmith MR. Immunology of the eye. In: The Eye and Immunology. St Louis, MO: CV Mosby Co, 1982: 82.
60. Staugus RE, Harvey DP, Ferrante A, Nandoskar M, Allison AC. Induction of tumor necrosis factor (TNF) and interleukin-1 (IL-1) by Pseudomonas aeruginosa and exotoxin A-induced suppression of lymphoproliferation and TNF, lymphotoxin, gamma interferon, and IL-1 production in human leukocytes. Infect Immun 1992;60:3162-3168.
61. Kernacki KA, Berk RS. Characterization of the inflammatory response induced by corneal infection with Pseudomonas. J Ocul Pharmacol 1994;10:281-288
62. Mondino BJ, Rabin BS, Kessler E, Gallo J, Brown SI. Corneal rings with gram-negative bacteria. Arch Ophthalmol 1977;95:2222-2225.
63. Hazlett LD, Rosen DD, Berk RS. Pseudomonas eye infection in cyclophosphamide-treated mice. Invest Ophthalmol Vis Sci 1977;16:649-652.
64. Weiss SJ. Tissue destruction by neutrophils. New Engl J Med 1989;321:327-329.
65. Steuhl KP, Dö;ring G, Henni A, Thiel HJ, Botzenhart K. Relevance of host-derived and bacterial factors in Pseudomonas aeruginosa corneal infections. Invest Ophthalmol Vis Sci 1987;28:1559-1568. (Pubitemid 17147788)
66. Chusid MJ, Nelson DB, Meyer LA. The role of the polymorphonuclear leucocyte in the induction of corneal edema. Invest Ophthalmol Vis Sci 1986;27:1466-1469.
67. Hobden JA, Engel LS, Callegan MC, Hill JM, Gebbardt BM, O'Callaghan RJ. Pseudomonas aeruginosa keratitis in leukopenic rabbits. Curr Eye Res 1993;12:461-467.
68. Hazlett LD, Zucker M, Berk RS. Distribution and kinetics of the inflammatory cell response to ocular challenge with Pseudomonas aeruginosa in susceptible versus resistant mice. Ophthalmic Res 1992;24:32-39.
69. Kessler E, Mondino BJ, Brown SI. The corneal response to Pseudomonas aeruginosa: histopathological and enzymatic characterization. Invest Ophthalmol Vis Sci 1977;16:116-125.
70. Hazlett LD, McClellan SM, Hume EBH, Dajcs JJ, O'Callaghan RJ, Willcox MDP. Extended-wear contact lens usage induces Langerhan's cell migration into cornea. Exp Eye Res 1999;69:575-577.
71. Hazlett LD, Moon M, Dawisha S, Berk RS. Age alters ADPase positive dendritic (Langerhans) cell response to P. aeruginosa ocular challenge. Curr Eye Res 1986;5:343-355.
72. Kwon B, Hazlett LD. Association of CD4+T cell-dependent keratitis with genetic susceptibility to Pseudomonas aeruginosa ocular infection. J Immunol 1997;159:6283-6290.
73. Verhagen C, Breebaart AC, Kijlstra A. The effects of complement depletion on corneal inflammation in rats. Invest Ophthalmol Vis Sci 1992: 33: 273-279.
74. Galardy RE, Cassabonne ME, Giese C, Gilbert JH, Lapierre F, Lopez H, Schaefer ME, Stack R, Sullivan M, Summers B et al. Low molecular weight inhibitors in corneal ulceration. Ann NY Acad Sci 1994: 732: 315-323.
75. Gray RD, Paterson CA. Application of peptide-based matrix metalloproteinase inhibitors in corneal ulceration. Ann NY Acad Sci 1994: 732: 206-216.
76. Welsh NH, Rauch AJ, Gaffin SL. Topical immunotherapy for Pseudomonas keratitis in rabbits: use of antilipopolysaccharide plasma. Br J Ophthalmol 1984: 68: 828-832.
77. Cho-Chung YS, Park YG, Lee YN. Oligonucleotides as transcription factor decoys. Curr Opin Mol Ther 1999: 1: 386-392.
78. Kim DK, Kim JJ, Kim JH, Woo YM, Kim S, Yoon DW, Choi CS, Kim I, Park WJ, Lee N, Jung SB, Ahn BY, Nam SW, Yoon SM, Choi WJ. Comparison of two immunization schedules for a Pseudomonas aeruginosa outer membrane proteins vaccine in burn patients. Vaccine 2001;19:1274-1283.
79. Moon MM, Hazlett LD, Hancock RE, Berk RS, Barrett R. Monocloncal antibodies provide protection against Pseudomonas aeruginosa infection. Invest Ophthalmol Vis Sci 1988: 29: 1277-1284.
80. Lee JC. An experimental vaccine that targets staphylococcal virulence. Trends Microbiol 1998;6:461-463.
81. Balaban N, Collins LV, Cullor JS, Hume EB, Medina-Acosta E, Viera da Motta O, O'Callaghan R, Rossitto PV, Shirtliff ME, Serafim da Silveira L, Tarkowski A, Torres JV. Prevention of diseases caused by Staphylococcus aureus using the peptide RIP. Peptides 2000;21:1301-1311.
82. Hume EB, Dajcs JJ, Moreau JM, O'Callaghan RJ. Immunization with alphatoxin toxoid protects the cornea against tissue damage during experimental Staphylococcus aureus keratitis. Infect Immun 2000;68:6052-6255.